Original Article Primary Angle Closure Glaucoma-associated Genetic Polymorphisms in Northeast Iran Ali Yousefian1, MD; Saeed Shokoohi-Rad1, MD; Mohammad Reza Abbaszadegan2, PhD Dorsa Morshedi Rad3, MS; Selma Zargari2, MS; Saman Milanizadeh2, MS Negar Morovatdar4, MD; Ramin Daneshvar1, MD, MS 1Eye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran 2Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran 3Immunology Research Center, Avicenna Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran 4Clinical Research Unit, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran ORCID: Ali Yousefian: https://orcid.org/0000-0002-9139-4601 Ramin Daneshvar: https://orcid.org/0000-0002-0884-0907 Abstract Purpose: To evaluate the association of five different polymorphisms from a genome- wide-associated study with susceptibility to glaucoma in the northeast Iranian popula- tion. Methods: Hundred and thirty patients with primary angle closure glaucoma (PACG) and 130 healthy controls were genotyped for the polymorphic regions with the aid of tetra- amplification refractory mutation system-polymerase chain reaction. The association of these variants with the disease susceptibility was measured statistically with the logistic regression method. Results: Hundred and thirty patients with PACG (53 males, 77 females) with a mean age of 64.5 ± 6.2 years and 130 healthy control subjects (51 males, 79 females) with a mean age of 64.0 ± 5.7 years were selected for evaluation. There was a significant association between rs3816415 (P = 0.005), rs736893 (P < 0.001), rs7494379 (P < 0.001), and rs1258267 (P = 0.02) with PACG susceptibility. This association could not be shown for rs3739821. Conclusion: It was revealed that studied variants in GLIS3, EPDR1, FERMT2, and CHAT genes can contribute to the incidence of PACG. Additional studies in other populations are needed to evaluate DPM2-FAM102A. Keywords: Polymorphism; Primary Angle Closure Glaucoma; rs3816415; rs736893; rs7494379; rs1258267 J Ophthalmic Vis Res 2020; 15 (1): 45–52 Correspondence to: Ramin Daneshvar, MD, MS. Khatam-al-Anbia Eye Hospi- tal, Abutaleb Cross, Mashhad 91959, Iran. E-mail: daneshvarr@mums.ac.ir Received: 21-02-2019 Accepted: 11-08-2019 Access this article online Website: https://knepublishing.com/index.php/JOVR DOI: 10.18502/jovr.v15i1.5942 INTRODUCTION Glaucoma is one of the leading causes of blind- ness worldwide. Approximately 70 million people This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. How to cite this article: Yousefian A, Shokoohi-Rad S, Abbaszadegan MR, Morshedi Rad D, Zargari S, Milanizadeh S, Morovatdar N, Daneshvar R. Primary Angle Closure Glaucoma-associated Genetic Polymorphisms in Northeast Iran. J Ophthalmic Vis Res 2020;15:45–52. © 2020 JOURNAL OF OPHTHALMIC AND VISION RESEARCH | PUBLISHED BY KNOWLEDGE E 45 http://crossmark.crossref.org/dialog/?doi=10.18502/jovr.v15i1.5942&domain=pdf&date_stamp=2019-07-17 https://knepublishing.com/index.php/JOVR PACG Genetic Polymorphisms; Yousefian et al are affected and it is predicted that by 2020, this number will rise to around 79.6 million globally.[1] The incidence of glaucoma varies in different populations and geographic regions. While primary open-angle glaucoma (POAG) is the most common type, primary angle closure glaucoma (PACG) is associated with a more severe presentation and bilateral blindness.[2–4] The visual function in PACG could be saved if early and proper treatments are adopted.[5] PACG is characterized by apposition between the peripheral iris and trabecular meshwork, which can ultimately lead to compromised outflow and high intraocular pressure (IOP).[6] Stress induced by IOP on optic disc results in compression, defor- mation, and remodeling of the lamina cribrosa with subsequent mechanical axonal damage and disruption of axonal transport or ischemic damage to the neural tissue.[7] PACG is a complex disease influenced by a combination of environmental and genetic risk fac- tors. Recently, COL18A1, which encodes collagen type XVIII, has been identified as a gene that affects angle closure in humans and can lead to PACG.[8] An unusually higher incidence among first- degree relatives of affected patients compared with the general population suggests that genetic risk factors may play an important role in the devel- opment of PACG.[9, 10] Another factor indicating a genetic influence in PACG development is the heritability for narrow-angle and a shallow anterior chamber (two important causes of disease) that are approximately 49% and 93%, respectively.[9, 11] Although several genome-wide association studies (GWASs) for PACG revealed multiple genetic variants correlated with disease susceptibility, these results demonstrate that the exact mechanisms by which the culprit gene could cause PACG is not completely understood and the association of different single nucleotide polymorphisms (SNPs) with glaucoma are still controversial.[12, 13] Among different reported variants, expression quantitative trait locus (eQTL) mapping databases indicate that rs7494379 on chromosome 14 posi- tion 53,411,391, gene locus FERMT2, rs736893 on chromosome 9 position 4,217,028, gene locus GLIS3, rs1258267 on chromosome 10 position 50,895,770, gene locus CHAT, rs3816415 on chromosome 7 position 37,988,311, gene locus EPDR1, and rs3739821 on chromosome 9 position 130,702,477, gene locus DPM2-FAM102A are sig- nificantly expressed in ocular anterior segment tissues such as iris, ciliary body, and trabecular meshwork,[14, 15] which mark them as potential vari- ants for PACG incidence. The current study aimed to evaluate the associ- ation of these five SNPs evaluated in GWAS with PACG susceptibility in the northeast of Iran. METHODS Population study This case-control study was conducted on sub- jects that were following up for PACG at Khatam Eye Hospital, a referral eye center in Mashhad, northeast of Iran, between 2017 and 2018. The case group included 130 patients with PACG that were diagnosed and followed by a glaucoma- trained ophthalmologist according to optic nerve exam, gonioscopy, IOP, and visual field changes and completed the interview of competency (53 males and 77 females). Individuals with primary angle closure and primary angle closure suspect (with only obstructed angle and/or increased IOP with no obvious optic nerve cupping or visual field defect) were not selected for the study and only patients with established optic nerve, head damage, or glaucomatous perimetric changes due to PACG were considered for evaluation. Control subjects were 130 healthy individuals (51 males and 79 females)[16] without any glaucoma findings or signs of angle closure in gonioscopy. Clinical information including age and sex was gathered. The Ethics Committee of the Mashhad University of Medical Sciences approved the study. SNP selection criteria The analyzed polymorphisms were selected on the basis of recent GWAS analysis and the databases prepared on the National Center for Biotechnology Information SNP Database (https://www.ncbi.nlm. nih.gov/snp/) (Access date: Dec 20, 2018) and lit- erature searches. We selected five validated SNPs with a minor allele frequency >1%.[17, 18] Genotyping DNA was extracted from the whole blood using the standard salting-out method 46 JOURNAL OF OPHTHALMIC AND VISION RESEARCH VOLUME 15, ISSUE 1, JANUARY-MARCH 2020 https://www.ncbi.nlm.nih.gov/snp/ https://www.ncbi.nlm.nih.gov/snp/ PACG Genetic Polymorphisms; Yousefian et al which was previously described by Miller et al.[19] Genotyping was carried out by tetra- amplification refractory mutation system- polymerase chain reaction (tetra-ARMS PCR). For amplification of the sequences containing polymorphic site, compatible and specified primers were designed using GeneRunner v3.01 (http://generunner.net/) and NCBI BLAST was used (https://www.ncbi.nlm.nih.gov/tools/primer-blast/) for ensuring the specificity. Properties of designed primers are listed in Table 1. PCR reaction was performed in a final volume of 15 𝜇l consisting 100 ng genomic DNA, 8 𝜇l of PCR master mix (Ampliqon A/S, Stenhuggervej 22, DK-5230 Odense M, Denmark), 0.5 𝜇M of inner primers, and 0.25 𝜇M of outer primers. Amplified products were visualized by 2% agarose gel elec- trophoresis. To confirm the results, 10% of samples were randomly re-genotyped by direct sequencing on ABI3130xl genetic analyzer (Thermo Fisher Scientific, USA) and the results were reproducible, with no discrepancy. Statistical analysis Chi-square test was used for determining the statistical significance of non-association between different variables. Logistic regression analysis was performed to estimate the association between polymorphism variants and the risk of PACG in different genders. The odds ratios (OR) and 95% confidence intervals (CI) were adjusted. Reported P-values were two-sided and the significance level was considered < 0.05. The SPSS, version 23.0 program (SPSS, Inc., Chicago, IL) was used for statistical analysis. Results This study included 130 patients with PACG (mean age: 64.5 ± 6.2 years) and 130 healthy control subjects (mean age: 64.0 ± 5.7 years). Age and sex of the participants were comparable between the two groups (P > 0.05). Detailed properties of the study subjects are demonstrated in Table 2. The tetra-ARMS PCR method was successfully applied to genotype five different SNPs. The asso- ciation of genotypes and allelic frequencies of five polymorphisms with PACG was determined. Genotype frequencies of all tested polymorphisms were in Hardy–Weinberg equilibrium. Genotype frequencies of analyzed SNPs are demonstrated in Table 3. As evident in Table 3, a highly significant asso- ciation and perhaps predisposing effect was found for G/A genotype of rs736893 in the GLIS3 gene and T/T genotype of rs7494379 in the FERMT2 gene (P < 0.001). Statistically meaningful associa- tion of rs1258267 in the CHAT gene and rs3816415 in the EPDR1 gene with PACG was also confirmed, but rs3739821 in the DPM2-FAM102A genes did not have any significant association with PACG frequency in our study population. The correlation of rs736893, rs1258267, and rs7494379 with the disease was stronger in males than in females, and rs3816415 had more associa- tion with the disease in females [Table 4]. Overall, a highly significant (P < 0.001) predis- posing effect for the C/T genotype of rs3816415 in the EPDR1 gene and G/A genotype of rs736893 in the GLIS3 was observed [Table 3]. Genotype fre- quency analysis revealed that heterozygote geno- type in rs736893, A/A genotype in rs1258267, C/C genotype in rs3816415, and heterozygote geno- type in rs3739821 were more frequent. However, genotype distribution in rs7494379 was not con- sistent and C/C genotype and C/T genotype were more frequent in cases and controls, respectively. DISCUSSION The results of the present study reveal significant differences in the frequencies of genotypes of EPDR1, GLIS3, CHAT, and FERMT2 polymorphisms between PACG patients and controls. The signifi- cantly higher frequencies of genotype G/A of GLIS3 and C/T of EPDR1 in patients with PACG than those in the controls indicated that these genotypes may be associated with a susceptibility to this disease. Previous studies showed controversial results on the association of PACG with genetic variants investigated in the current study. Zhuang et al found that only SNPs rs3753841 in COL11A1, rs1258267 in CHAT, and rs736893 in GLIS3 are associated with PACG in northern Chinese people; however, other studies demonstrated EPDR1, GLIS3, CHAT, FERMT2, and DPM2- FAM102A polymorphisms contribution to the disease susceptibility.[12, 18, 20] FERMT2 encodes a protein called pleckstrin- homology-domain-containing family C member JOURNAL OF OPHTHALMIC AND VISION RESEARCH VOLUME 15, ISSUE 1, JANUARY-MARCH 2020 47 http://generunner.net/ https://www.ncbi.nlm.nih.gov/tools/primer-blast/ PACG Genetic Polymorphisms; Yousefian et al Table 1. Tetra-ARMS primer details. SNP Sequence Product length (nucleotide) Tm (degree centigrade) rs736893 forward 5’TGCTACCAGGACTTGTGGTTGTG3’ 240 57reverse 5’CTATGTTCTTCCCAGCACACATTC3’ forward 5’ACAATAGCCTAAGAGCACAGAGG3’ 130 reverse 5’GGAACCATGACTCTTGGATTTAAA3’ rs1258267 forward 5’GAGGAAGGCTCATTGCGATGG3’ 327 61reverse 5’TCCTGACTCAAATCTCCTGCCTTC3’ forward 5’TGAGATTCTGATGAGCAAGTGCATG3’ 130 reverse 5’CCAGGTTGCCTGCACCTGCT3’ rs3816415 forward 5’TGGTGGCTTGGTCAATCTG3’ 216 57reverse 5’TCATGTGCCTAGTGTTTATAAACA3’ forward 5’ATTACTAGCTAGGCAATCACTTTAC3’ 96 reverse 5’ATGCTCGGTCTGACCTGTG3’ rs3739821 forward 5’AGAAGATCGTTACCTGCCAGCC3’ 215 61reverse 5’GGGAACACACTCACACCTCGTG3’ forward 5’CGAGTGTGCAGCCTGACCAGT3’ 145 reverse 5’AGTGACTTGCCTGTCCCAGAGAG3’ rs7494379 forward 5’GCACCATTCCACCAAATAAGCAC3’ 286 60reverse 5’CTTAACGTGATCATTAAGTATGGTATTCA3’ forward 5’TCCACTTCTGTGAGATGCAATGTAC3’ 155 reverse 5’CATTTATGTTGGAGTTGCATGTTAGG3’ SNP, single nucleotide polymorphism Table 2. Characteristics of the study groups Study Groups PACG patients Control Group P-value Number of Subjects 130 130 Gender 0.450 Male, n (%) 53(40.8) 51(39.2) Female, n (%) 77(59.2) 79(60.8) Age (years) Mean (SD) 64.5(6.2) 64.0(5.7) 0.657 n, number; PACG, primary angle closure glaucoma; SD, standard deviation 1 (PLEKHC1), a component of the extracellular matrix, and could thus have a role in cell adhe- sion; cell–cell adhesion has been proposed as an important process in the pathogenesis of PACG.[21] GLIS3 is a member of the GLI-similar subfamily of Krüppel-like zinc-finger proteins.[22] Earlier studies have shown that mutations in GLIS3 cause neonatal diabetes and congenital hypothyroidism.[23] SNP markers mapping close to GLIS3 have been observed to be significantly associated with type 1 diabetes in Europeans (rs7020673),[24] type 2 diabetes in East Asians (rs7041847),[25] and fasting plasma glucose lev- els in a large meta-analysis of European collec- tions (rs7034200);[26] however, metabolic path- ways through which zinc-finger activation could 48 JOURNAL OF OPHTHALMIC AND VISION RESEARCH VOLUME 15, ISSUE 1, JANUARY-MARCH 2020 PACG Genetic Polymorphisms; Yousefian et al Table 3. Genotype frequencies Genotypes Snps PACG patients N (%) Controls N (%) OR (95%CI) P-value rs736893 < 0.001 G/G 10(7.6) 46(35.3) Reference Reference G/A 120(92.4) 84(64.7) 6.77(3.2–14.2) < 0.001 A/A 0 0 – – rs1258267 0.02 A/A 97(74.6) 113(86.9) Reference Reference A/G 30(23) 17(13.1) 2(1–3.9) 0.033 G/G 3(2.4) 0 1.5(1.3–1.7) 0.078 rs3816415 0.005 C/C 120(92.3) 129(99.2) Reference Reference C/T 10(7.7) 1(0.8) 10.75(1.3-85.4) 0.025 T/T 0 0 – – rs3739821 0.42 T/T 28(21.5) 23(17.6) Reference Reference T/C 79(60.7) 76(58.4) 1.69(0.7–3.7) 0.18 C/C 23(17.8) 31(24) 1.46(0.7–2.7) 0.23 rs7494379 < 0.001 C/C 48(36.9) 80(61.5) Reference Reference C/T 50(38.4) 37(28.4) 2.28(1.3-3.9) 0.004 T/T 32(24.7) 13(10.1) 4.08(1.9-8.5) < 0.001 contribute to pathogenesis of PACG is not well understood.[12] CHAT on chromosome 10 encodes choline acetyltransferase, an enzyme responsible for the synthesis of the neurotransmitter acetylcholine, which has a role in pupillary constriction. Anti- cholinergic medications can precipitate acute PACG through pupillary dilatation mechanisms and subsequent pupillary block. Therefore, it is plausible that natural genetic variation in a gene influencing acetylcholine metabolism could alter the risk for PACG.[27] EPDR1 encodes a glycosylated type II trans- membrane protein known as ependymin-related 1. It potentially has a role in cell adhesion, and it has some similarity to protocadherins and ependymins.[26] As mentioned earlier, disturbance in cell–cell adhesion could have some roles in the pathogenesis of PACG.[12] SNP rs3739821 is located in an intergenic region between DPM2 and FAM102A, a gene yet to be fully characterized. Mutations in DPM2 have been linked to congenital defects in glycosylation,[28] leading to severe pathological neurological phe- notypes. Although not much is known about FAM102A, except that its expression is sensitive to the addition of 𝛽-estradiol, the nearby PIP5KL1 gene has been reported to be involved in cell proliferation[29] and potentially in tumorigenesis. Expression analysis revealed that all three genes (FAM102A, DPM2, and PIP5KL1) were expressed in all eye tissues tested, thus providing bio- logical support for their potential role in PACG development.[12] The expression of all these genes in the cornea, lens, retina, choroid, and optic nerve head confirms the function of these genes in these tissues.[12] The activity of these genes products in the ocular system can explain how different variations in these genes may contribute to the PACG. In conclusion, characterizations of these varia- tions suggest that they can contribute to PACG sus- ceptibility; however, the penetrance of the alleles may be low. Being able to divide the population JOURNAL OF OPHTHALMIC AND VISION RESEARCH VOLUME 15, ISSUE 1, JANUARY-MARCH 2020 49 PACG Genetic Polymorphisms; Yousefian et al Table 4. Genotype frequencies in male and female groups Genotypes Gender PACG patients N (%) Controls N (%) OR (95%CI) P-value rs736893 <0.001 G/G Male 5(9) 19(37) Reference Reference G/A 48(91) 32(63) 5(1.5–16.5) 0.007 A/A 0(0) 0(0) – – G/G Female 5(7) 27(34) Reference Reference G/A 72(93) 52(66) 7(2.5–22.2) 0.01 A/A 0(0) 0(0) – – rs1258267 0.02 A/A Male 39(74) 43(84) Reference Reference A/G 12(22) 8(16) 2.7(0.8–9.2) 0.1 G/G 2(4) 0(0) 10(0.1–11.1) 0.98 A/A Female 58(75) 70(89) Reference Reference A/G 18(23) 9(11) 1.5(0.6–4) 0.3 G/G 1(2) 0(0) 11(0.6–27.4) 0.8 rs3816415 0.005 C/C Male 47(89) 51(11) Reference Reference C/T 6(11) 0(0) 18(0.2–23.4) 0.98 T/T 0(0) 0(0) – – C/C Female 73(95) 78(99) Reference Reference C/T 4(5) 1(1) 3.6(0.3–25.4) 0.2 T/T 0(0) 0(0) – – rs3739821 0.42 T/T Male 12(23) 5(10) Reference Reference T/C 28(53) 31(61) 0.4(0.1–1.5) 0.19 C/C 13(24) 15(29) 0.3(0.1–1.3) 0.11 T/T Female 16(21) 18(23) Reference Reference T/C 15(66) 45(57) 1(0.4–2.6) 0.83 C/C 10(13) 16(20) 0.7(0.2–2.4) 0.66 rs7494379 < 0.001 C/C Male 16(31) 32(63) Reference Reference C/T 22(41) 14(27) 2.6(0.9–7.4) 0.063 T/T 15(75) 5(10) 8.4(2.2–32.1) 0.002 C/C Female 32(42) 48(61) Reference Reference C/T 28(36) 23(29) 1.6(0.7–3.5) 0.2 T/T 17(22) 7(10) 3(1–8.8) 0.04 50 JOURNAL OF OPHTHALMIC AND VISION RESEARCH VOLUME 15, ISSUE 1, JANUARY-MARCH 2020 PACG Genetic Polymorphisms; Yousefian et al into risk categories would allow tailored screening, prognosis, and treatment programs according to the risk of each individual. Additional studies in other populations with more participants should be considered to evaluate the association of DPM2- FAM102A with the disease. Financial Support and Sponsorship The authors would like to thank the Vice Chancellor of Research, Mashhad University of Medical Sci- ences, Mashahd, Iran (Grant # 950495). Conflicts of Interest There are no conflicts of interest. REFERENCES 1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90:262–267. 2. Shastry BS. Genetic susceptibility to primary angle closure glaucoma (PACG). Discov Med 2013;15:17–22. 3. Cheng J-W, Zong Y, Zeng Y-Y, Wei R-L. The preva- lence of primary angle closure glaucoma in adult Asians: a systematic review and meta-analysis. PLOS ONE 2014;9:e103222. 4. Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014;121:2081–2090. 5. Chen M-S, Chang C-C, Lin C-P, Wang P-C, Lin L-R, Hou P- K, et al. Role of vascular endothelial growth factor in the breakdown of the blood-aqueous barrier after retinal laser photocoagulation in pigmented rabbits. J Ocul Pharmacol Th 2012;28:83–88. 6. Quigley HA, Addicks EM, Green WR, Maumenee AE. Optic nerve damage in human glaucoma: II. The site of injury and susceptibility to damage. Arch Ophthalmol 1981;99:635–649. 7. Burgoyne CF, Downs JC, Bellezza AJ, Suh JK, Hart RT. The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog Retin Eye Res 2005;24:39–73. 8. Suri F, Yazdani S, Chapi M, Safari I, Rasooli P, Daftarian N, et al. COL18A1 is a candidate eye iridocorneal angle- closure gene in humans. Hum Mol Genet 2018;27:3772– 3786. 9. Amerasinghe N, Zhang J, Thalamuthu A, He M, Vithana EN, Viswanathan A, et al. The heritability and sibling risk of angle closure in Asians. Ophthalmology 2011;118:480– 485. 10. Sihota R, Ghate D, Mohan S, Gupta V, Pandey RM, Dada T. Study of biometric parameters in family members of pri- mary angle closure glaucoma patients. Eye 2008;22:521– 527. 11. Yazdani S, Akbarian S, Pakravan M, Afrouzifar M. Preva- lence of angle closure in siblings of patients with primary angle-closure glaucoma. J Glaucoma 2015;24:149–153. 12. Khor CC, Do T, Jia H, Nakano M, George R, Abu-Amero K, et al. Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma. Nat Genet 2016;48:556–562. 13. Lee Y, Song G. TNF-𝛼-308 A/G and-238 A/G polymor- phisms and susceptibility to glaucoma: a meta-analysis. Genet Mol Res 2015;14:4966–4977. 14. Westra H-J, Peters MJ, Esko T, Yaghootkar H, Schurmann C, Kettunen J, et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet 2013;45:1238–1243. 15. Consortium G. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 2015;348:648–660. 16. Li Z, Khor CC. Current development in genome wide association studies of glaucoma. Curr Ophthalmol Rep 2018;6:79–85. 17. Rong SS, Tang FY, Chu WK, Ma L, Yam JC, Tang SM, et al. Genetic associations of primary angle-closure disease: a systematic review and meta-analysis. Ophthalmology 2016;123:1211–1221. 18. Nongpiur ME, Cheng CY, Duvesh R, Vijayan S, Baskaran M, Khor CC, et al. Evaluation of primary angle-closure glaucoma susceptibility loci in patients with early stages of angle-closure disease. Ophthalmology 2018;125:664– 670. 19. Miller S, Dykes D, Polesky H. A simple salting out pro- cedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215. 20. Zhuang W, Wang S, Hao J, Xu M, Chi H, Piao S, et al. Genotype-ocular biometry correlation analysis of eight pri- mary angle closure glaucoma susceptibility loci in a cohort from Northern China. PLOS ONE 2018;13:e0206935. 21. Shen Z, Ye Y, Kauttu T, Seppänen H, Vainionpää S, Wang S, et al., Novel focal adhesion protein kindlin-2 promotes the invasion of gastric cancer cells through phosphorylation of integrin 𝛽1 and 𝛽3. J Surg Oncol 2013;108:106–112. 22. Kim YS, Nakanishi G, Lewandoski M, Jetten AM. GLIS3, a novel member of the GLIS subfamily of Krüppel-like zinc finger proteins with repressor and activation functions. Nucleic Acids Res 2003;31:5513–5525. 23. Senée V, Chelala C, Duchatelet S, Feng D, Blanc H, Cossec JC, et al. Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nat Genet 2006;38:682–687. 24. Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009;41:703–707. 25. Cho YS, Chen CH, Hu C, Long J, Ong RT, Sim X, et al. Meta- analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat JOURNAL OF OPHTHALMIC AND VISION RESEARCH VOLUME 15, ISSUE 1, JANUARY-MARCH 2020 51 PACG Genetic Polymorphisms; Yousefian et al Genet 2012;44:67. 26. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010;42:105–116. 27. Wan Y, Li S, Gao Y, Tang L, Cao W, Sun X. COL11A1 polymorphisms are associated with primary angle-closure glaucoma severity. J Ophthalmol 2019;2019:2604386. 28. Barone R, Aiello C, Race V, Morava E, Foulquier F, Riemersma M, et al. DPM2-CDG: a muscular dystrophy– dystroglycanopathy syndrome with severe epilepsy. Ann Neurol 2012;72:550–558. 29. Shi L, Zhao M, Luo Q, Ma YM, Zhong JL, Yuan XH, et al. Overexpression of PIP5KL1 suppresses cell proliferation and migration in human gastric cancer cells. Mol Biol Rep 2010;37:2189–2198. 52 JOURNAL OF OPHTHALMIC AND VISION RESEARCH VOLUME 15, ISSUE 1, JANUARY-MARCH 2020